|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
DK2519522T3
(en)
|
2009-12-30 |
2014-12-08 |
Arqule Inc |
SUBSTITUTED IDAZOPYRIDINYL AMINOPYRIDINE COMPOUNDS
|
|
JP5894161B2
(ja)
|
2010-08-25 |
2016-03-23 |
ネオファーム カンパニー, リミテッド |
新規の複素環化合物及びこれを用いた炎症性疾患治療用組成物
|
|
JP5719028B2
(ja)
|
2010-10-06 |
2015-05-13 |
グラクソスミスクライン エルエルシー |
Pi3キナーゼ阻害剤としてのベンズイミダゾール誘導体
|
|
EP2691375B1
(en)
|
2011-03-31 |
2016-03-16 |
Bayer Intellectual Property GmbH |
Substituted benzimidazoles as mps-1 kinase inhibitors
|
|
KR20190015600A
(ko)
|
2011-06-24 |
2019-02-13 |
아르퀼 인코포레이티드 |
치환된 이미다조피리디닐-아미노피리딘 화합물
|
|
US8815854B2
(en)
|
2011-06-24 |
2014-08-26 |
Arqule, Inc. |
Substituted imidazopyridinyl compounds
|
|
EP2865672A4
(en)
*
|
2012-06-22 |
2015-12-16 |
Sumitomo Chemical Co |
CONDENSED HETEROCYCLIC COMPOUND
|
|
CN102924460B
(zh)
*
|
2012-11-05 |
2015-12-16 |
南京师范大学 |
一种4H-吡咯并[1,2-a]苯并咪唑衍生物及其合成方法和应用
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
CN103130811B
(zh)
*
|
2013-03-11 |
2015-02-25 |
河南师范大学 |
一种5,6-二氢吡唑并[1,5-c]喹唑啉类化合物的合成方法
|
|
US8952177B2
(en)
|
2013-03-15 |
2015-02-10 |
Janssen Pharmaceutica Nv |
1,2,6-substituted benzimidazoles as FLAP modulators
|
|
CA2902833A1
(en)
|
2013-03-15 |
2014-09-18 |
Syngenta Participations Ag |
Microbicidally active imidazopyridine derivatives
|
|
US9682971B2
(en)
|
2013-03-15 |
2017-06-20 |
Janssen Pharmaceutica Nv |
1,2,5-Substituted benzimidazoles as flap modulators
|
|
CA2915838C
(en)
|
2013-06-21 |
2023-04-18 |
Zenith Epigenetics Corp. |
Bicyclic bromodomain inhibitors
|
|
EP3010918B1
(en)
|
2013-06-21 |
2018-08-15 |
Zenith Epigenetics Ltd. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
JP6542212B2
(ja)
|
2013-07-31 |
2019-07-10 |
ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. |
ブロモドメイン阻害剤としての新規キナゾリノン
|
|
DK3071206T3
(da)
|
2013-11-22 |
2021-05-25 |
CL BioSciences LLC |
Gastrinantagonister (eg yf476, netazepid) til behandling og forebyggelse af osteoporose
|
|
CN103965136B
(zh)
*
|
2014-05-07 |
2016-09-07 |
苏州波菲特新材料科技有限公司 |
一种制备n-甲基噻唑啉-2-酮类化合物的方法
|
|
EP3227281A4
(en)
|
2014-12-01 |
2018-05-30 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
HK1246273B
(en)
|
2014-12-01 |
2019-12-06 |
恒翼生物医药(上海)股份有限公司 |
Substituted pyridines as bromodomain inhibitors
|
|
EP3230277B1
(en)
|
2014-12-11 |
2019-09-18 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
HK1245247A1
(zh)
|
2014-12-17 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
US10189841B2
(en)
|
2015-11-20 |
2019-01-29 |
Forma Therapeutics, Inc. |
Purinones as ubiquitin-specific protease 1 inhibitors
|
|
CN106519250A
(zh)
*
|
2016-09-29 |
2017-03-22 |
辽宁石油化工大学 |
含氮小分子有机配体调节荧光发射性质的一维链状铜配位聚合物的制备方法
|
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
EP3562306B1
(en)
|
2016-12-29 |
2025-02-26 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
FI3562487T3
(fi)
|
2016-12-29 |
2023-12-14 |
Ji Xing Pharmaceuticals Hong Kong Ltd |
Metalloentsyymi-inhibiittoriyhdisteitä
|
|
MX2021011775A
(es)
|
2017-04-26 |
2023-01-10 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
US11292791B2
(en)
|
2017-09-15 |
2022-04-05 |
Forma Therapeutics, Inc. |
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
|
|
GB201800688D0
(en)
|
2018-01-16 |
2018-02-28 |
Redag Crop Prot Ltd |
Agricultural chemicals
|
|
GB201806320D0
(en)
|
2018-04-18 |
2018-05-30 |
Cellcentric Ltd |
Process
|
|
IL279734B2
(en)
|
2018-06-29 |
2024-11-01 |
Forma Therapeutics Inc |
Inhibiting creb binding protein (cbp)
|
|
JP7640458B2
(ja)
|
2018-10-05 |
2025-03-05 |
アンナプルナ バイオ インコーポレイテッド |
Apj受容体活性に関連する状態を処置するための化合物および組成物
|
|
CA3126224A1
(en)
|
2019-01-08 |
2020-07-16 |
Corxel Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
US12351577B2
(en)
|
2019-03-15 |
2025-07-08 |
Forma Therapeutics, Inc. |
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
|
|
CN110982806B
(zh)
*
|
2019-08-30 |
2022-09-02 |
浙江工业大学 |
一种蛋白质芳基衍生物及其制备方法
|
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN111206260B
(zh)
*
|
2020-02-12 |
2022-03-22 |
齐鲁工业大学 |
一种吡啶并[1,2-a]苯并咪唑类化合物的电化学合成方法
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|